Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamine K Antagonist (VKA) Treatment”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Not applicableNot Yet RecruitingNCT07570511
What this trial is testing

Point of Care Testing INR in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVitamine K Antagonist (VKA) Treatment
Central Hospital, Nancy, France 150
Not applicableStudy completedNCT04117048
What this trial is testing

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

Who this might be right for
Vitamine K Antagonist (VKA) TreatmentInternational Normalized Ratio (INR) Measure at HomeThromboembolic Pathology
Medicalps 128